Notice Pursuant to the National Cooperative Research and Production Act of 1993-Subcutaneous Drug Development & Delivery Consortium, Inc., 74288 [2024-20745]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
74288
Federal Register / Vol. 89, No. 177 / Thursday, September 12, 2024 / Notices
Corporation, Murray Hill, NJ; Numerica
Corporation, Fort Collins, CO;
Oklahoma State University Oklahoma
Aerospace Institute for Education and
Research, Stillwater, OK; One World
Clean Energy, Inc., Louisville, KY;
Optics 1, Inc., Bedford, NH; Parametric
Solutions, Inc., Jupiter, FL; Physical
Sciences, Inc., Andover, MA; Practical
Energetics Research, Inc., Huntsville,
AL; Pratt Miller Engineering and
Fabrication, New Hudson, MI; Quantum
Research International, Inc., Huntsville,
AL; Qynergy Corporation, Albuquerque,
NM; Radiance Technologies, Inc.,
Huntsville, AL; Rolls Royce North
America, Indianapolis, IN; Saronic
Technologies, Inc., Austin, TX; Science
Applications International Corporation,
Crane, IN; Scientia LLC, Bloomington,
IN; Scientific Research Corporation,
Atlanta, GA; Shared Spectrum
Company, Vienna, VA; Shield AI, Inc.,
San Diego, CA; Simulation
Technologies, Inc., Huntsville, AL;
Smart Information Flow Technologies
LLC dba SIFT LLC, Minneapolis, MN;
SRC, Inc., North Syracuse, NY; SRI,
Menlo Park, CA; Stellant Systems,
Williamsport, PA; Swarmbotics AI, Inc.,
Scottsdale, AZ; Teledyne FLIR LLC,
Wilsonville, OR; TrellisWare
Technologies, Inc., San Diego, CA;
Triton Systems, Inc., Chelmsford, MA;
University of Notre Dame du Lac, Notre
Dame, IN; Utah State University Space
Dynamics Laboratory, North Logan, UT;
and VT Milcom, Virginia Beach, VA,
have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and EMC2 intends
to file additional written notifications
disclosing all changes in membership.
On January 11, 2024, EMC2 filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on March 13, 2024 (89 FR 18439).
DEPARTMENT OF JUSTICE
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
DEPARTMENT OF JUSTICE
[FR Doc. 2024–20744 Filed 9–11–24; 8:45 am]
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—National Armaments
Consortium
BILLING CODE P
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Subcutaneous Drug
Development & Delivery Consortium,
Inc.
Notice is hereby given that, on April
25, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Subcutaneous Drug
Development & Delivery Consortium,
Inc. has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Comera Life Sciences,
Woburn, MA, has withdrawn as a party
to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and Subcutaneous
Drug Development & Delivery
Consortium, Inc. intends to file
additional written notifications
disclosing all changes in membership.
On October 26, 2020, Subcutaneous
Drug Development & Delivery
Consortium, Inc. filed its original
notification pursuant to section 6(a) of
the Act. The Department of Justice
published a notice in the Federal
Register pursuant to section 6(b) of the
Act on December 3, 2020 (85 FR 78148).
The last notification was filed with
the Department on February 2, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on April 16, 2024 (89 FR 26926).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–20745 Filed 9–11–24; 8:45 am]
BILLING CODE P
Antitrust Division
Notice is hereby given that, on May 6,
2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
VerDate Sep<11>2014
20:43 Sep 11, 2024
Jkt 262001
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
et seq. (‘‘the Act’’), National Armaments
Consortium (‘‘NAC’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Olson Custom Designs,
Indianapolis, IN; 1Aardvark LLC,
Chantilly, VA; Aerospace Business
Development Associates, Inc., Fairborn,
OH; Airtonics, Tucson, AZ; Alkemix
Corp., Laguna Hills, CA; ApolloTech
MSI CORP, Elmwood Park, NJ; Applied
Science and Technology Research
Organization of America, Bethesda, MD;
Bowden Manufacturing Corp.,
Willoughby, OH; Caesar Creek Software,
Miamisburg, OH; Cahaba Federal
Solutions, Huntsville, AL; Cambium
Biomaterials, Mojave, CA; D. Wheatley
Enterprises, Inc. (DWE), Belcamp, MD;
Decision Engineering Corp., Freehold,
NJ; Discovery Machine, Inc.,
Williamsport, PA; Edge Case Research,
Pittsburgh, PA; Friedman Research
Corp., Austin, TX; GN Aerospace GTC,
LLC, Fort Worth, TX; GoHypersonic
Inc., Dayton, OH; Hermeus Corp.,
Atlanta, GA; In Space LLC, Lafayette,
IN; L3 Harris Forecex, Nashville, TN; L3
Harris Technologies Integrated Systems
LP dba L3 Harris Aeromet, Tulsa, OK;
Lacamas Laboratories, Inc., Portland,
OR; Millennitek, Knoxville, TN;
Modular Genetics, Inc., Lincoln, MA;
Multiverse US, Inc., New York, NY;
Nautical Structures Industries, Inc.,
Largo, FL; NCD Technologies, Madison,
WI; Odyssey Systems Consulting Group,
Wakefield, MA; Ombra, Tampa, FL;
Omni Federal, Gainesville, VA; OMP
Logistics Corporation, Paramus, NJ;
Pratt & Miller Engineering & Fabrication
LLC, New Hudson, MI; Precision
Products, Inc., Dalton, GA; Radial
Solutions, Inc. (RSI), Huntsville, AL; R–
DEX Systems, Woodstock, GA; Shifts,
Inc., Rosslyn, VA; Sierra Technical
Services, Inc., Tehachapi, CA; SIXGEN,
LLC, Annapolis, MD; SMI Solutions,
Inc., Huntington, WV; Sroka Inc.,
Strongsville, OH; The Will-Burt
Company, Orrville, OH; University of
Dayton, Dayton, OH; Wegmann USA,
Inc., Lynchburg, VA; Wiggins Lift Co,
Inc., Oxnard, CA; WMD Tech LLC,
Boise, ID; Woodlawn Manufacturing,
Marshall, TX; and Zeus Research and
Technology, Inc., Huntsville, AL, have
been added as parties to this venture.
Also, 50 BMG Supply LLC, Canton,
OH; ADA Technologies, Inc., Littleton,
CO; Advanced American Technologies
LLC, Oak Ridge, TN; Aerobotix, Inc.,
E:\FR\FM\12SEN1.SGM
12SEN1
]]>Agencies
[Federal Register Volume 89, Number 177 (Thursday, September 12, 2024)]
[Notices]
[Page 74288]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20745]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Subcutaneous Drug Development & Delivery
Consortium, Inc.
Notice is hereby given that, on April 25, 2024, pursuant to section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Subcutaneous Drug Development &
Delivery Consortium, Inc. has filed written notifications
simultaneously with the Attorney General and the Federal Trade
Commission disclosing changes in its membership. The notifications were
filed for the purpose of extending the Act's provisions limiting the
recovery of antitrust plaintiffs to actual damages under specified
circumstances. Specifically, Comera Life Sciences, Woburn, MA, has
withdrawn as a party to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and Subcutaneous Drug Development &
Delivery Consortium, Inc. intends to file additional written
notifications disclosing all changes in membership.
On October 26, 2020, Subcutaneous Drug Development & Delivery
Consortium, Inc. filed its original notification pursuant to section
6(a) of the Act. The Department of Justice published a notice in the
Federal Register pursuant to section 6(b) of the Act on December 3,
2020 (85 FR 78148).
The last notification was filed with the Department on February 2,
2024. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on April 16, 2024 (89 FR 26926).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-20745 Filed 9-11-24; 8:45 am]
BILLING CODE P
